Improvement of Pain Relief of Fentanyl Citrate Drug Encapsulated in Nanostructured Lipid Carrier: Drug Formulation, Parameter Optimization, in vitro and in vivo Studies
Open Access
- 1 May 2020
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 14, 2033-2045
Abstract
Introduction: In this study, the encapsulation of fentanyl citrate as an opioid drug with hydrophobic nature in the nanostructured lipid carrier (NLC) is performed. Methods: For encapsulation of fentanyl citrate drug, hot homogenization method is used. The pharmacokinetics of encapsulated fentanyl citrate for pain relief of rats are investigated. The influence of important variables such as the ratio of liquid lipid to the total amount of lipids, surfactant type and concentration on the particle size is investigated using response surface method. Results: Results show that the optimal NLC size is about 90 nm with PDI value around 0.2 and zeta potential of − 25± 4.01 mV. Characterization analysis of optimal nanostructure shows successful encapsulation of the drug in nanostructure with a spherical morphology of the NLC structure. Results of drug release from commercial fentanyl citrate ampoule and NLC form indicate a control drug release from the NLC within 72 hours in comparison to the commercial ampoule. In vivo studies show that fentanyl citrate-loaded NLC not only has the potential to relieve pain in doses equal to commercial drug but also it can reduce the dose of the drug about 50%. Conclusion: In conclusion, NLC form of fentanyl citrate can increase the efficacy of the drug by appropriate drug distribution in the body and can reduce the risks of overdose.Keywords
This publication has 29 references indexed in Scilit:
- Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailabilityInternational Journal of Pharmaceutics, 2010
- A Tribute to Dr. Paul A. J. Janssen: Entrepreneur Extraordinaire, Innovative Scientist, and Significant Contributor to AnesthesiologyAnesthesia & Analgesia, 2008
- Lipid Nanoparticles (SLN®, NLC®) for Cutaneous Drug Delivery:Structure, Protection and Skin EffectsJournal of Biomedical Nanotechnology, 2007
- Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous systemColloids and Surfaces B: Biointerfaces, 2005
- Application of statistical experimental design for optimization of alkaline protease production from Bacillus sp. RGR-14Process Biochemistry, 2004
- An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough PainJournal of Pain and Symptom Management, 2000
- Antinociception and Side Effects of L‐and D‐Dipalmitoylphosphatidyl Choline Liposome‐Encapsulated Alfentanil after Spinal Delivery in Rats*Basic & Clinical Pharmacology & Toxicology, 1995
- Antinociception and Side Effects of Liposome-Encapsulated Alfentanil After Spinal Delivery in RatsAnesthesia & Analgesia, 1994
- Liposome Encapsulation Prolongs Alfentanil Spinal Analgesia and Alters Systemic Redistribution in the RatAnesthesiology, 1992
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977